中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
Chinese Journal of Experimental Surgery
2015年
9期
2166-2168
,共3页
文坤明%黄妍%黎江%苏弦%陈正权%曾庆良
文坤明%黃妍%黎江%囌絃%陳正權%曾慶良
문곤명%황연%려강%소현%진정권%증경량
结直肠癌%多药耐药%姜黄素%P-糖蛋白
結直腸癌%多藥耐藥%薑黃素%P-糖蛋白
결직장암%다약내약%강황소%P-당단백
Colorectal cancer%Multi-drug resistance%Curcumin%P-glycoprotein
目的 探讨姜黄素(Cur)对具有多药耐药特性的人结直肠癌耐奥沙利铂(Oxa)细胞株耐药的逆转作用及其是否与下调耐药蛋白P-糖蛋白(P-gp)有关.方法 采用WST-1试剂检测Cur对两种人结直肠癌耐Oxa细胞株(SW480/OxR及SW620/OxR)的半数抑制浓度(IC50),选择比IC50低一浓度梯度的Cur+2μmol/L Oxa作用于两种耐药细胞48h(称为实验组),与仅加入2μmol/L的Oxa对照组比较,采用流式细胞术检测细胞凋亡;采用实时定量聚合酶链反应(Real-time PCR)检测编码P-gp的多药耐药基因-1(MDR-1) mRNA表达;采用流式间接法检测P-gp阳性细胞百分率.结果 实验组与对照组比较:(1) SW480/OxR细胞凋亡率由(4.23±1.65)%上升到(32.15±3.98)%,SW620/OxR细胞凋亡率由(5.08±1.82)%上升到(30.69±2.94)%,两种耐药细胞实验组细胞凋亡率均明显高于其对照组(P<0.05);(2)两种耐药细胞MDR-1 mRNA表达抑制率均超过50%(P<0.05);(3)两种耐药细胞P-gp蛋白阳性细胞百分率明显下降(P<0.05).结论 Cur具有逆转结直肠癌耐药细胞株耐药的作用,可能与下调耐药蛋白P-gp表达有关.
目的 探討薑黃素(Cur)對具有多藥耐藥特性的人結直腸癌耐奧沙利鉑(Oxa)細胞株耐藥的逆轉作用及其是否與下調耐藥蛋白P-糖蛋白(P-gp)有關.方法 採用WST-1試劑檢測Cur對兩種人結直腸癌耐Oxa細胞株(SW480/OxR及SW620/OxR)的半數抑製濃度(IC50),選擇比IC50低一濃度梯度的Cur+2μmol/L Oxa作用于兩種耐藥細胞48h(稱為實驗組),與僅加入2μmol/L的Oxa對照組比較,採用流式細胞術檢測細胞凋亡;採用實時定量聚閤酶鏈反應(Real-time PCR)檢測編碼P-gp的多藥耐藥基因-1(MDR-1) mRNA錶達;採用流式間接法檢測P-gp暘性細胞百分率.結果 實驗組與對照組比較:(1) SW480/OxR細胞凋亡率由(4.23±1.65)%上升到(32.15±3.98)%,SW620/OxR細胞凋亡率由(5.08±1.82)%上升到(30.69±2.94)%,兩種耐藥細胞實驗組細胞凋亡率均明顯高于其對照組(P<0.05);(2)兩種耐藥細胞MDR-1 mRNA錶達抑製率均超過50%(P<0.05);(3)兩種耐藥細胞P-gp蛋白暘性細胞百分率明顯下降(P<0.05).結論 Cur具有逆轉結直腸癌耐藥細胞株耐藥的作用,可能與下調耐藥蛋白P-gp錶達有關.
목적 탐토강황소(Cur)대구유다약내약특성적인결직장암내오사리박(Oxa)세포주내약적역전작용급기시부여하조내약단백P-당단백(P-gp)유관.방법 채용WST-1시제검측Cur대량충인결직장암내Oxa세포주(SW480/OxR급SW620/OxR)적반수억제농도(IC50),선택비IC50저일농도제도적Cur+2μmol/L Oxa작용우량충내약세포48h(칭위실험조),여부가입2μmol/L적Oxa대조조비교,채용류식세포술검측세포조망;채용실시정량취합매련반응(Real-time PCR)검측편마P-gp적다약내약기인-1(MDR-1) mRNA표체;채용류식간접법검측P-gp양성세포백분솔.결과 실험조여대조조비교:(1) SW480/OxR세포조망솔유(4.23±1.65)%상승도(32.15±3.98)%,SW620/OxR세포조망솔유(5.08±1.82)%상승도(30.69±2.94)%,량충내약세포실험조세포조망솔균명현고우기대조조(P<0.05);(2)량충내약세포MDR-1 mRNA표체억제솔균초과50%(P<0.05);(3)량충내약세포P-gp단백양성세포백분솔명현하강(P<0.05).결론 Cur구유역전결직장암내약세포주내약적작용,가능여하조내약단백P-gp표체유관.
Objective To investigate the reversal multidrug resistance effects of curcumin on human colorectal cancer cell lines resistant to oxaliplatin and whether its mechanism is involved in downregulation of the expression of P-glycoprotein (P-gp).Methods The 50% inhibitory concentration (IC50) values of curcumin to the two colorectal cancer cell lines resistant to oxaliplatin (SW480/OxR and SW620/ OxR) were obtained by WST-1 reagent,which is one kind of cell proliferation assay.Later experiments included in the experimental group and the control group.In the experimental group,the two kinds of drug-resistant cells were exposed to the previous experiment IC50 concentrations of curcumin plus 2 μmol/L oxaliplatin for 48 h,while in the control group,the two kinds of drug-resistant cells were cultured in medium containing in 2 μmol/L oxaliplatin.In the two groups of the two kinds of drug-resistant cells:apoptosis was detected by flow cytometrythe mRNA expression levels of multidrug resistance (MDR)-1 were detected by real time-polymerase chain reaction (Real-time PCR) and the percentage of P-gp positive cells was disclosed by indirect method of flow cytometry.Results In the control group,the apoptosis rate of SW480/OxR and SW620/OxR cells were respectively (4.23 ± 1.65) % and (5.08 ± 1.82) %,while the apoptosis rate of the two drug-resistant cells in their experimental group respectively rose to (32.15 ± 3.98) % and (30.69 ± 2.94) %.The apoptosis rate of two drug-resistant cells in the experimental group were significantly higher than that of their control group (P < 0.05).In the experimental groups,the mRNA expression of MDR-1 of the two drug-resistant cells decreased more than 50% (P < 0.05),and the percentage of positive cells of P-gp protein were significantly decreased (P < 0.05),when compared with that in their control group.Conclusion Curcumin can reverse drug resistance in colorectal cancer cell lines resistant to oxaliplatin,its effect may be associated with lowered P-gp expression.